The capital markets experienced a strong rebound in late-2024. Equity issuance increased significantly, driven by technology and healthcare companies. U.S. markets raised about US$273 billion across IPOs, follow-ons, and convertibles. This was a notable increase compared with 2023. Convertibles contributed nearly one-third of this total, marking their highest share in ten years. Despite the overall surge, IPOs raised only US$30 billion across approximately 63 major U.S. listings during the year.
Investor Returns Strengthen Confidence
Although IPO volumes remained modest, performance was impressive. The average six-month return for 2024 IPOs reached 60.7%. Many investors benefited, especially those backing technology and healthcare stocks. International markets also posted strong results, supported by investor appetite for quality companies. However, the relatively small IPO proceeds suggest many firms preferred staying private longer. Some postponed listings until conditions improved, highlighting the cautious stance among issuers.
Regulatory Reforms Shape Market Dynamics
Regulators acted to enhance transparency and strengthen capital markets. Several jurisdictions proposed stricter rules for smaller issuers and required clearer fee disclosures. These measures were intended to protect investors and promote fairness. At the same time, large institutions reshaped the financial landscape. BlackRock’s acquisition of HPS Investment Partners for US$12 billion underlined the growing influence of private credit. Private funds are gaining ground as corporates shift away from traditional bank lending.
Rise of Private Credit and Alternatives
Private credit continues expanding, driven by demand for higher yields and flexible structures. Corporates are increasingly turning to these funds for financing. This trend is reshaping how companies approach listings and capital raising. Private credit provides new opportunities but also intensifies competition with public markets. Regulators must balance innovation with safeguards. Investor protection and disclosure requirements remain priorities as market structures evolve rapidly.
Outlook for Capital Markets in 2025
The outlook for 2025 is cautiously optimistic. Analysts expect stronger IPO pipelines in technology, healthcare, and sustainability sectors. Firms that delayed 2024 listings could finally proceed. Investors will likely focus on higher-quality issuers instead of speculative entrants. Interest rates, inflation control, and global stability remain critical factors. If rates ease, capital costs will decline. This could boost IPO issuance and sustain positive momentum in global capital markets.
